Literature DB >> 1681810

Characterization of beta 1- and beta 2-adrenoceptors in rat skeletal muscles.

Y S Kim1, R D Sainz, P Molenaar, R J Summers.   

Abstract

Binding studies with (-)-[125I]cyanopindolol (ICYP) were conducted to characterize beta-adrenoceptors in plantaris and soleus muscles of rats (male, 250-300 g). The distribution of beta 1- and beta 2-adrenoceptors in different muscle fiber types, identified in serial sections by succinic dehydrogenase (SDH) staining, was studied by autoradiography. The densities of binding sites (Bmax, fmol/mg protein) were 5.4 +/- 0.9 (mean +/- SEM) in plantaris and 11.5 +/- 2.0 in soleus muscle. In plantaris muscle, monophasic competition curves were observed when binding experiments were performed using CGP20712A (50 pM to 0.5 mM), a beta 1-adrenoceptor selective antagonist, or ICI 118,551 (50 pM to 20 microM), a beta 2-adrenoceptor selective antagonist, to compete for ICYP binding. Analysis with LIGAND revealed a single binding site with a KD value of 2.41 +/- 0.56 nM (mean +/- SEM) for ICI 118,551 and 8.93 +/- 3.00 microM for CGP 20712A, indicating the presence of a homogeneous population of beta 2-adrenoceptors. In soleus muscle, competition curves were biphasic with 16-21% beta 1-adrenoceptors. Autoradiographic studies supported the findings from binding studies with membrane homogenates. The ICYP binding pattern was associated closely with the muscle fiber types identified by SDH staining. Propranolol-resistant binding sites were observed, and these sites were associated with muscle fibers positive to SDH staining.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1681810     DOI: 10.1016/0006-2952(91)90516-8

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  28 in total

1.  Salbutamol modifies the neuromuscular junction in a mouse model of ColQ myasthenic syndrome.

Authors:  Grace M McMacken; Sally Spendiff; Roger G Whittaker; Emily O'Connor; Rachel M Howarth; Veronika Boczonadi; Rita Horvath; Clarke R Slater; Hanns Lochmüller
Journal:  Hum Mol Genet       Date:  2019-07-15       Impact factor: 6.150

2.  Cardiac implications for the use of beta2-adrenoceptor agonists for the management of muscle wasting.

Authors:  Peter Molenaar; Lu Chen; William A Parsonage
Journal:  Br J Pharmacol       Date:  2006-03       Impact factor: 8.739

Review 3.  ASAS-SSR Triennnial Reproduction Symposium: Looking Back and Moving Forward-How Reproductive Physiology has Evolved: Fetal origins of impaired muscle growth and metabolic dysfunction: Lessons from the heat-stressed pregnant ewe.

Authors:  Dustin T Yates; Jessica L Petersen; Ty B Schmidt; Caitlin N Cadaret; Taylor L Barnes; Robert J Posont; Kristin A Beede
Journal:  J Anim Sci       Date:  2018-06-29       Impact factor: 3.159

4.  Role of cyclic AMP sensor Epac1 in masseter muscle hypertrophy and myosin heavy chain transition induced by β2-adrenoceptor stimulation.

Authors:  Yoshiki Ohnuki; Daisuke Umeki; Yasumasa Mototani; Huiling Jin; Wenqian Cai; Kouichi Shiozawa; Kenji Suita; Yasutake Saeki; Takayuki Fujita; Yoshihiro Ishikawa; Satoshi Okumura
Journal:  J Physiol       Date:  2014-10-24       Impact factor: 5.182

5.  CL 316,243, a selective beta3-adrenergic agonist, inhibits protein breakdown in rat skeletal muscle.

Authors:  Luiz Carlos C Navegantes; Neusa M Z Resano; Amanda Martins Baviera; Renato H Migliorini; Isis C Kettelhut
Journal:  Pflugers Arch       Date:  2005-08-10       Impact factor: 3.657

6.  Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes.

Authors:  M N Sillence; N G Moore; G G Pegg; D B Lindsay
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

7.  Characterization of propranolol-resistant (-)-[125I]-cyanopindolol binding sites in rat soleus muscle.

Authors:  S J Roberts; P Molenaar; R J Summers
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

8.  CL316,243, a selective β3-adrenoceptor agonist, activates protein translation through mTOR/p70S6K signaling pathway in rat skeletal muscle cells.

Authors:  Maria Concetta Miniaci; Mariarosaria Bucci; Rita Santamaria; Carlo Irace; Anna Cantalupo; Giuseppe Cirino; Pietro Scotto
Journal:  Pflugers Arch       Date:  2013-01-19       Impact factor: 3.657

9.  Classical and atypical binding sites for beta-adrenoceptor ligands and activation of adenylyl cyclase in bovine skeletal muscle and adipose tissue membranes.

Authors:  M N Sillence; M L Matthews
Journal:  Br J Pharmacol       Date:  1994-03       Impact factor: 8.739

10.  G(s)alpha deficiency in skeletal muscle leads to reduced muscle mass, fiber-type switching, and glucose intolerance without insulin resistance or deficiency.

Authors:  Min Chen; Han-Zhong Feng; Divakar Gupta; James Kelleher; Kathryn E Dickerson; Jie Wang; Desmond Hunt; William Jou; Oksana Gavrilova; Jian-Ping Jin; Lee S Weinstein
Journal:  Am J Physiol Cell Physiol       Date:  2009-01-21       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.